Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wufeng Chicheng Biotech is a prominent Chinese biotechnology firm focused on the research, development, and large-scale production of tannin-based derivatives and plant extracts. Established in 2004 and headquartered in Hubei, the company utilizes Galla Chinensis as a primary raw material to manufacture high-quality tannic acid, gallic acid, and various gallate esters. These products serve as critical intermediates and additives in the pharmaceutical, nutraceutical, and food processing sectors. As a publicly traded entity on the NEEQ, the company maintains advanced manufacturing facilities and adheres to international quality standards to supply a global clientele. Their expertise lies in the deep processing of natural forest products into high-value chemical components.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wufeng Chicheng Biotech.